The Supreme Court takes up a case today that could have big implications on Wall Street. Investment banks are accused of conspiring to inflate IPO prices during the '90s dot-com boom and subsequent bust. And a whole lotta money hangs in the balance.
Democrats are unveiling an initiative today that would force the U.S. to include worker protections in future trade deals — a move that could sink some of the White House's free trade aspirations in Latin America.
Biologics are among the most expensive drugs in the world — in part because the government has never cleared a path to allow generic drugmakers to compete. That could soon change, but there are safety roadblocks ahead.
Washington is offering billions in incentives to get utility companies to build a new wave of nuclear reactors to meet growing energy demands. The companies are lining up for the subsidies, but investors and consumers are weary.
A House subcommittee meets today to consider the Pentagon's $10 billon request for the next phase of our missile defense system. That includes a sizeable chunk to repair seven missile silos ruined by rain last year.
As some economists worry that U.S. housing troubles could trigger a full-scale global financial crisis, Britain's home builders are still enjoying a robust market. And now two of the biggest are joining forces.
Theranostics will use micro-ray technology to pinpoint proteins in individual cancer patients to help doctors decide what drugs will be most effective — an innovation borne of a joint effort from the non- and for-profit worlds.